Standout Papers

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV 2019 2026 2021 2023 425
  1. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV (2019)
    François Venter, Michelle Moorhouse et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 26 standout
Sub-graph 1 of 12

Citing Papers

A review of graph neural networks: concepts, architectures, techniques, challenges, datasets, applications, and future directions
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
2 intermediate papers

Works of Ambar Qavi being referenced

Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
2020

Author Peers

Author Last Decade Papers Cites
Ambar Qavi 490 238 353 9 640
J Tyler Lonergan 436 318 420 11 610
Sally Bebawy 444 235 303 21 621
Nomathemba Chandiwana 459 238 355 24 599
Gerlinde M. Michl 543 445 639 9 730
Francesca Rocchi 136 157 123 25 708
Joe Eron 507 391 121 12 738
HR Brodt 383 228 216 11 601
Bradley W. Kosel 311 162 237 6 617
Barbara Bastow 402 357 169 19 594
Johnstone J. Kumwenda 399 197 131 13 531

All Works

Loading papers...

Rankless by CCL
2026